Neuraxis, Inc. NRXS

7.56 (0.19) (2.45%) as of 25 Sep
Market cap
$97.3M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
11.55 6.05 3.36 4.48 4.48 4.48
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
(21.32) (9.25) (3.14) (19.23) (19.23) (19.23)
P/B ratio
12.14 7.88 0.00 0.00 0.00 0.00
Price to Tangible BV
13.21 8.27 0.00 0.00 0.00 0.00
EV/Sales
10.17 4.69 3.34 4.48 4.48 4.48
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
(5.64) (2.07) (1.23) (5.06) (5.06) (5.06)
EV/FCF
(5.50) (2.03) (1.21) (5.03) (5.03) (5.03)
Quick Ratio
1.85 1.62 0.08 0.06 0.31 2.19
Current Ratio
2.05 1.75 0.13 0.07 0.34 2.44
Net Debt/EBITDA
0.64 0.53 0.05 0.08 (0.04) 0.39
Debt/Assets
0.00% 0.00% 0.00% 0.00% 57.76% 11.17%
Debt/Equity
0.00 0.00 0.00 0.00 (0.53) 0.19
Asset Turnover
0.64 1.02 2.47 2.40 1.53 0.00
Operating CF/Net income
0.75 0.72 0.46 0.48 0.59 0.96
Capex/Depreciation
(2.20) (0.17) (0.01) (0.45) 0.00 0.00
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00
ROE
(315.63%) (2,560.29%) 419.26% 149.37% (924.80%) 0.00%
ROA
(154.37%) (320.97%) (1,469.95%) (426.59%) (212.78%) 0.00%
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(285.58%) (439.59%) 940.93% 74.54% 548.65% (245.89%)
Average Days of Receivables
20.01 33.24 10.86 23.71 15.46 58.87
Research and Development Expense of Revenue
13.83% 16.14% 6.88% 8.40% 7.47% 8.64%
Selling, General and Administrative Expense of Revenue
289.77% 336.84% 351.70% 206.14% 184.48% 279.92%
Intangible Assets out of Total Assets
0.04 0.02 0.21 0.05 0.03 0.01
Share Based Compensation of Revenue
16.72% 8.45% 0.00% 1.02% 0.00% 0.00%
Graham Net Nets
0.07 0.10 (0.20) (0.93) (0.93) (0.93)
Graham Number
0.00 0.00 7.39 0.00 0.00 0.00
Earnings Yield
(20.70%) (51.06%) (221.22%) (57.76%) (57.76%) (57.76%)
Free Cash Flow Yield
(16.02%) (38.24%) (82.50%) (19.86%) (19.86%) (19.86%)
Revenue per Share
0.39 0.39 0.76 1.34 0.44 0.31
Operating CF per Share
(0.71) (0.88) (2.06) (1.15) (0.36) (0.67)
Capex per Share
(0.01) 0.00 (0.02) (0.03) 0.00 0.00
Free Cash Flow per Share
(0.72) (0.89) (2.08) (1.18) (0.36) (0.67)
Cash per Share
0.55 0.53 0.02 0.13 0.05 0.31
Shareholders Equity per Share
0.37 0.30 (0.43) (2.78) (0.13) 0.27
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
0.37 0.30 (0.43) (2.78) (0.13) 0.27
Free Cash Flow
(6.56) (6.13) (6.77) (2.36) (2.23) (4.14)
Working Capital
2.94 1.83 (1.64) (6.50) (0.93) 1.45
Capital Expenditures
(0.13) (0.03) (0.07) (0.06) 0.00 (0.03)
Net Current Asset Value
2.73 1.58 (1.67) (6.58) (1.10) 1.32
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.04 0.01 0.03 0.02 0.00 0.00
Net Profit Margin
(241.37%) (314.71%) (594.58%) (178.05%) (138.79%) (223.57%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.79 1.82 55.56 1.55 0.24 0.18
Cash ROIC
(77.81%) (107.35%) 512.05% 44.85% 3,785.95% (115.33%)
Accounts Receivable Turnover
16.21 16.90 19.87 18.53 12.76 0.00
Accounts Payable Turnover
1.53 0.40 0.22 0.29 1.44 0.00
Inventory Turnover
3.74 11.05 8.75 6.81 6.41 0.00
Average Days of Payables
90.39 601.85 1,449.17 1,955.96 377.56 124.88
Days of Inventory on Hand
166.71 44.67 25.51 59.09 30.59 81.03
Average Receivables
0.22 0.16 0.12 0.14 0.21 —
Average Payables
0.37 0.90 1.40 1.04 0.32 —
Average Inventory
0.15 0.03 0.03 0.04 0.07 —
Average Assets
5.58 2.63 1.00 1.12 1.78 —
Average Common Equity
2.73 0.33 (3.49) (3.20) 0.41 —

Fold the line items

Columns are period end dates